Results
1052
Companies which are more than 50% undervalued based on analyst price target.
1052 companies
Strategy
Market Cap: US$98.5b
Operates as a bitcoin treasury company in the United States, Europe, the Middle East, Africa, and internationally.
MSTR
US$344.75
7D
4.0%
1Y
138.1%
Atlassian
Market Cap: US$44.3b
Provides a collaboration software that enables organizations to connect all teams through a system of work that unlocks productivity at scale worldwide.
TEAM
US$169.05
7D
-3.3%
1Y
3.7%
DexCom
Market Cap: US$26.5b
A medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.
DXCM
US$67.45
7D
-11.5%
1Y
-4.2%
Trade Desk
Market Cap: US$21.7b
Operates as a technology company in the United States and internationally.
TTD
US$44.47
7D
-1.5%
1Y
-59.4%
Summit Therapeutics
Market Cap: US$14.0b
A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.
SMMT
US$18.89
7D
-0.3%
1Y
-22.6%
QXO
Market Cap: US$13.9b
Distributes roofing, waterproofing, and other building products in the United States.
QXO
US$20.62
7D
-0.7%
1Y
36.7%
Duolingo
Market Cap: US$13.3b
Operates as a mobile learning platform in the United States, the United Kingdom, and internationally.
DUOL
US$290.90
7D
-5.5%
1Y
8.4%
Sprouts Farmers Market
Market Cap: US$11.8b
Engages in the retailing of fresh, natural, and organic food products in the United States.
SFM
US$120.41
7D
-11.5%
1Y
13.9%
Aurora Innovation
Market Cap: US$11.2b
Operates as a self-driving technology company in the United States.
AUR
US$6.06
7D
6.9%
1Y
21.2%
BioMarin Pharmaceutical
Market Cap: US$10.4b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$54.36
7D
0.5%
1Y
-23.1%
U-Haul Holding
Market Cap: US$10.0b
Operates as a do-it-yourself moving and storage operator for household and commercial goods in the United States and Canada.
UHAL
US$56.32
7D
-2.1%
1Y
-24.5%
Moderna
Market Cap: US$9.8b
A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.
MRNA
US$25.24
7D
7.4%
1Y
-61.6%
Chime Financial
Market Cap: US$8.8b
A financial technology company, provides digital consumer banking and payment solutions.
CHYM
US$23.75
7D
0.4%
1Y
n/a
Liberty Broadband
Market Cap: US$8.7b
Engages in a range of communications businesses in the United States.
LBRD.K
US$60.41
7D
-0.2%
1Y
0.1%
Corcept Therapeutics
Market Cap: US$8.5b
Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
CORT
US$80.52
7D
10.5%
1Y
90.6%
Primo Brands
Market Cap: US$8.4b
Operates as a branded beverage company in North America.
PRMB
US$22.48
7D
-6.5%
1Y
-11.1%
Revolution Medicines
Market Cap: US$8.1b
A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.
RVMD
US$43.54
7D
-6.5%
1Y
-4.1%
VinFast Auto
Market Cap: US$7.6b
Engages in the design and manufacture of electric vehicles (EV), e-scooters, and e-buses in Vietnam, Canada, and the United States.
VFS
US$3.23
7D
-1.5%
1Y
-11.7%
Wingstop
Market Cap: US$7.1b
Wingstop Inc., together with its subsidiaries, franchises and operates restaurants under the Wingstop brand.
WING
US$253.55
7D
-4.7%
1Y
-39.6%
Legend Biotech
Market Cap: US$6.3b
Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.
LEGN
US$34.01
7D
2.7%
1Y
-29.9%
Avidity Biosciences
Market Cap: US$5.9b
A biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs).
RNA
US$41.06
7D
-8.2%
1Y
-7.7%
Cytokinetics
Market Cap: US$5.8b
A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.
CYTK
US$48.66
7D
-4.8%
1Y
-9.5%
Axsome Therapeutics
Market Cap: US$5.8b
A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
AXSM
US$115.95
7D
-2.1%
1Y
21.0%
Nuvalent
Market Cap: US$5.5b
A clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.
NUVL
US$76.67
7D
-4.7%
1Y
-29.0%
Caesars Entertainment
Market Cap: US$5.3b
Operates as a gaming and hospitality company.
CZR
US$25.56
7D
1.9%
1Y
-38.3%
Clearwater Analytics Holdings
Market Cap: US$5.2b
Develops and provides a Software-as-a-Service (SaaS) solution for automated investment data aggregation, reconciliation, accounting, and reporting services to insurers, investment managers, corporations, institutional investors, and government entities in the United States and internationally.
CWAN
US$18.23
7D
-7.0%
1Y
-27.9%
Bath & Body Works
Market Cap: US$5.2b
Operates as a specialty retailer of home fragrance, personal and body care, soaps, and sanitizer products.
BBWI
US$25.09
7D
-7.8%
1Y
-14.3%
Arrowhead Pharmaceuticals
Market Cap: US$4.2b
Develops medicines for the treatment of intractable diseases in the United States.
ARWR
US$30.69
7D
3.3%
1Y
47.5%
Array Digital Infrastructure
Market Cap: US$4.2b
Provides wireless telecommunications services in the United States.
AD
US$48.34
7D
-5.2%
1Y
-12.3%
Vaxcyte
Market Cap: US$4.1b
A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.
PCVX
US$31.75
7D
-1.3%
1Y
-72.4%
WillScot Holdings
Market Cap: US$4.1b
Provides turnkey temporary space solutions in the United States, Canada, and Mexico.
WSC
US$22.57
7D
-1.9%
1Y
-43.3%
Qfin Holdings
Market Cap: US$4.0b
Qfin Holdings, Inc., together with its subsidiaries, operate AI- driven credit-tech platform under the Qifu Jietiao brand in the People’s Republic of China.
QFIN
US$30.33
7D
6.9%
1Y
17.7%
ADMA Biologics
Market Cap: US$3.8b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$15.91
7D
-1.2%
1Y
-20.4%
Freshworks
Market Cap: US$3.8b
A software development company, provides software-as-a-service products in North America, Europe, the Middle East, Africa, Asia Pacific, and internationally.
FRSH
US$12.89
7D
3.5%
1Y
13.8%
Americold Realty Trust
Market Cap: US$3.7b
Americold is a global leader in temperature-controlled logistics real estate and value-added services.
COLD
US$12.83
7D
-7.0%
1Y
-54.8%
Zai Lab
Market Cap: US$3.6b
A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.
ZLAB
US$32.65
7D
-0.5%
1Y
49.4%